UNSPSC 51392413: Dopamine lutine

This classification denotes a catecholamine with the molecular formula C8H7NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z3OC8499KG, chemically known as indole-5,6-diol, but more generally known as dopamine lutine, which bears US NIH Compound Identifier 114683. European Medicines Agency schedules dopamine lutine or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06365MIG. Most nations, for tariff purposes, schedule dopamine lutine under HS 29222900. SMILES: C1C[NH]C2C1CC(C(C2)O)O.

UNSPSC 51392413 Dopamine lutine is a Commodity code that appears in state and local procurement primarily for pharmaceutical products and drug-related supplies, though recent solicitation activity shows a disconnect between the code's nominal scope and the actual work being procured. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the county's Community Health Building and an initial two-year contract term with one-year renewal option; vendors must cover all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify and drug-free workplace requirements. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather market intelligence on implementing a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, soliciting vendor experience with direct contracting for self-insured employee health plans and state agencies, negotiated net pricing models, and value-based contracting arrangements. The code shows limited recent activity focused on state health agencies and county health departments rather than a broad base of issuing bodies.

Geographic activity concentrates in Florida and Texas based on recent postings. The Seminole County solicitation represents municipal health procurement supporting community health initiatives, while the Texas HHS Commission RFI reflects state-level pharmacy program innovation. No other states or jurisdictions appear in the recent-opportunities block. The code itself does not clearly map to the pharmaceutical supply and direct-pharmacy-contracting work actually being solicited under these notices, suggesting either a coding inconsistency in the source records or that the code is rarely used for state and local procurement in this category. Firms pursuing this code should verify jurisdiction coding practices before investing business development resources, as recent activity is sparse and geographically narrow.